
HCV virus genotype 1b (isolate BK) Genome polyprotein 1406-1415, KLSGLGINAV
Description
About HCV virus genotype 1b (isolate BK) Genome polyprotein 1406-1415, KLSGLGINAV
The Hepatitis C Virus (HCV) genotype 1b (isolate BK) Genome polyprotein Peptide (IEDB: 32165) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Genome polyprotein Peptide, H-KLSGLGINAV-OH (Uniprot: P26663 aa: 1406-1415) from JPT is produced under strict quality control and quality management.
HCV virus genotype 1b (isolate BK) Genome polyprotein 1406-1415, KLSGLGINAV - Specifications
- Peptide sequence: H-KLSGLGINAV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Hepatitis
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for HCV virus genotype 1b (isolate BK) Genome polyprotein 1406-1415, KLSGLGINAV
References:
Read References with JPT’s Antigen Peptides
HCV virus genotype 1b (isolate BK) Genome polyprotein 1406-1415, KLSGLGINAV has been described in:
Determinants of viral clearance and persistence during acute hepatitis C virus infection., J Exp Med, 2001 (PMID: 11714747)
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man., Sci Transl Med, 2012 (PMID: 22218690)
Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade., Front Immunol, 2022 (PMID: 35874702)
Documentation
Documentation for HCV virus genotype 1b (isolate BK) Genome polyprotein 1406-1415, KLSGLGINAV
Properties
Properties of HCV virus genotype 1b (isolate BK) Genome polyprotein 1406-1415, KLSGLGINAV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Hepatitis |
Layout: | Freeze-dried in glass vial |
Organism: | Hepatitis C Virus (HCV) |
Protein Name: | Genome polyprotein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to HCV virus genotype 1b (isolate BK) Genome polyprotein 1406-1415, KLSGLGINAV
Information | Values |
---|---|
Sequence: | H-KLSGLGINAV-OH |
Specifications: | 10mer peptide as TFA salt |